1.Adrenogenital Syndrome with Congenital Adrenal Hyperplasia.
Myoung Sung MOON ; Kwang Nam KIM ; Woo Gill LEE
Journal of the Korean Pediatric Society 1984;27(5):511-515
No abstract available.
Adrenal Hyperplasia, Congenital*
;
Adrenogenital Syndrome*
2.Relationship between HPV Infection and bcl-2 Protein Expression and Apoptosis in Invasive and In Situ Squamous Cell Carcinoma of the Uterine Cervix.
Myoung Ja CHUNG ; Kyu Yun JANG ; Woo Sung MOON ; Myoung Jae KANG ; Dong Geun LEE
Korean Journal of Pathology 1999;33(9):702-708
Human papillomavirus (HPV) 16/18 is a causative agent of uterine cervical carcinoma. HPV 16/18 can alter cell cycle regulation through apoptosis. Bcl-2 is an important regulatory gene of apoptosis. A study was done to evaluate the relation between HPV 16/18 and bcl-2 and apoptosis in 21 cases of carcinoma in-situ (CIS), 5 cases of microinvasive carcinoma and 23 cases of invasive squamous cell carcinoma. HPV 16/18 was detected by hybrid capture system (HCS), bcl-2 protein by immunohistochemical method and apoptosis by using the hematoxylin-eosin stained slide. The results were as follows: Expression of the bcl-2 protein was 43% (9/21) in CIS and 26% (6/23) in invasive carcinoma. Expression of the bcl-2 protein was 42% (5/12) in CIS with HPV 16/18 infection, 44% in CIS without HPV 16/18 infection, 20% (2/10) in invasive carcinoma with HPV 16/18 infection and 31% (4/13) in invasive carcinoma without HPV 16/18 infection. Mean apoptotic index (mAI) was 3.36 in CIS, 5.23 in microinvasive and 6.25 in invasive carcinoma. mAI was 3.66 in CIS with HPV 16/18 infection, 2.86 in CIS without HPV 16/18 infection, 6.18 in invasive carcinoma with HPV 16/18 infection and 6.30 in invasive carcinoma without HPV 16/18 infection. Based on these results, we conclude that there are no correlation between HPV infection and bcl-2, and between HPV infection and apoptosis in invasive and in situ carcinoma of the uterine cervix, and apoptosis is increased according to tumor progression.
Apoptosis*
;
Carcinoma, Squamous Cell*
;
Cell Cycle
;
Cervix Uteri*
;
Female
;
Genes, Regulator
;
Humans
3.Hyalinizing Trabecular Carcinoma of the Thyroid Gland: A report of two cases.
Kyu Yun JANG ; Joo Heon KIM ; Myoung Ja CHUNG ; Woo Sung MOON ; Myoung Jae KANG
Korean Journal of Pathology 2000;34(4):318-322
We report two cases of hyalinizing trabecular carcinoma (HTC) of the thyroid gland. These two patients were euthyroid women aged 36 and 65 years of age. The tumors were encapsulated and measured 0.8 and 4.0 cm in diameter, respectively. Histologically, the tumors were composed of a compact proliferation of cells in a lobular and trabecular pattern with an intervening hyalinized, fibrotic vascular stroma. Occasionally the cells were arrayed in microfollicles. Multiple and serial sections showed cords of tumor cells invading into the capsule in both cases and vascular invasion in one case. These findings suggested that HTCs are a malignant counterpart of hyalinizing trabecular adenoma, similar to conventional follicular tumor. Positive immunostaining of tumor cells for thyroglobulin and negative staining for high molecular weight cytokeratin, cytokeratin 19, neuron specific enolase, chromogranin, and synaptophysin allowed distinction from medullary carcinoma. Even though HTCs are an heterogeneous group of tumors, the present two cases are probably variants of follicular carcinoma rather than papillary carcinoma.
Adenoma
;
Carcinoma, Medullary
;
Carcinoma, Papillary
;
Female
;
Humans
;
Hyalin*
;
Keratin-19
;
Keratins
;
Molecular Weight
;
Negative Staining
;
Phosphopyruvate Hydratase
;
Synaptophysin
;
Thyroglobulin
;
Thyroid Gland*
4.Thrombospondin-1 and -2 Expressions in Hepatocellular Carcinomas: an Association with Tumor Angiogenesis and p53 Overexpression.
Jae Sin CHUNG ; Ho Sung PARK ; Hyun Jin SON ; Myoung Jae KANG ; Woo Sung MOON
Korean Journal of Pathology 2005;39(4):215-221
Background : It has been suggested that thrombospondin (TSP) is a p53-dependent negative regulator of tumor angiogenesis. TSP expression and localization in hepatocellular carcinomas (HCCs) and its association with overexpression of p53 protein were investigated. Methods : TSP-1 and -2 expressions were examined in 40 HCC specimens by immunohistochemical staining and in 4 HCC cell lines by Western blotting. In addition, p53 protein expression and microvessel density (MVD) were correlated with the TSP expression. Results : Strong immu- nopositivity for TSP-1 was observed in fibroblasts, vascular endothelial cells, and some vas- cular smooth muscle cells of the stroma in 18 cases (45%), and in tumor cells in 3 cases (7.5%) of 40 cases of HCC. Immunoreactivity for TSP-2 was observed in only the sinusoidal lining cells of the tumor in 15 cases (46%), and in tumor cells in 2 cases (6%) of 32 cases of HCC. TSP-1 expression was inversely correlated with MVD (p=0.028), but TSP-2 expression did not show any correlation with MVD. Although p53 was overexpressed in 17 cases, there was no significant correlation between TSP and p53 expressions. None of the HCC cell lines expressed TSP-1 or -2. Conclusions : These findings indicate that TSP-1 is mainly derived from nonparenchymal cells, and may decrease tumor angiogenesis in HCC.
Angiogenesis Inhibitors
;
Blotting, Western
;
Carcinoma, Hepatocellular*
;
Cell Line
;
Endothelial Cells
;
Fibroblasts
;
Microvessels
;
Myocytes, Smooth Muscle
;
Thrombospondin 1
;
Thrombospondins
5.Eccrine spiradenoma: A report of two cases.
Woo Sung MOON ; Dong Geun LEE ; Myoung Ja JEONG ; Myoung Jae KANG ; Ho Yeul CHOI ; Sang Ho KIM
Korean Journal of Pathology 1993;27(4):402-406
Eccrine spiradenomas are clinically characterized by a solitary, tender mass and they are situated on the upper parts of the body, predominantly on the ventral aspect. We herein report two cases of eccrine spiradenoma in 35-year-old man and 53-year-old woman, which located on upper extremity and inguinal region. The masses are round, well circumscribed and measuring 0.7x0.5x0.5 cm, 5x4.5x3 cm in size, respectively. Histopathologically, the tumor consists of masses of two types of cells, intensely staining cells and pale staining cells, usually arranged in chains, cords and pseudoglands. Immunostainings for low molecular cytokeratin, high molecular cytokeratin, carcinoembryonic antigen, and S-100 protein show positivity in neoplastic cells. Electron microscopically, the tumor was composed of three types of cells, i. e. 1) round or ovoid tumor cells in shape with scanty cytoplasm and poorly developed intracytoplasmic orgenelles, 2) spindle shaped dark cells interconnected by desmosomes, 3) large epithelial cells with abundant cytoplasm and cytoplasmic intermediate filaments which formed glandular structures. The large epithelial cells joint each other by desmosomal attachments and luminal cells featured small numbers of microvilli, but either secretory granules nor ductal type granules were noticed.
Female
;
Male
;
Humans
6.Echocardiographic Evaluation of Pulmonary Arterial Hypertension in Pediatric Congenital Heart disease.
Myoung Sung MOON ; In Hee PARK ; Heung Jae LEE ; Hahng LEE ; Keun Soo LEE
Journal of the Korean Pediatric Society 1984;27(10):971-981
No abstract available.
Echocardiography*
;
Heart Defects, Congenital*
;
Hypertension*
7.Effects of Parenteral Carnitine Supplemantation in Very Low Birth Weight Infants Receiving Totla Parentareal Nutrition.
Myoung Jae CHOEY ; Jeong Nyun KIM ; Sung Keun MOON ; Chul Young JUNG
Korean Journal of Perinatology 1998;9(1):19-25
PURPOSE: Carnitine plays a key role in the oxidation of fatty acids by facilitating their transport. As very low birth weight(VLBW) infants receiving total parenteral nutrition(TPN) with limited oral intake are likely to be carnitine-deficient state, they require exogenous supplementation of carnitine, however, effects of it remains controversial. To demonstrate effects of parenteral camitine supplementation on fat metabolism, weight gain and clinical outcome. We analyzed plasma levels of biochemical markers, changes of weight, and incidence of complications in 23 VLBW infants receiving TPN. METHOD: We randomly assigned 23 VLBW infants(<32 wks of gestational age) receiving TPN to carnitine-supplemented(100mg/kg per day) group(n=10) and control(n=13). Plasma total (TC), free(FC), and acyl carnitine(AC) levels and serum cholesterol, triglyceride and free fatty acid levels were measured before and 2 weeks after carnitine supplementation. RESULT: Decrements in TC for 2 weeks were significantly lower in carnitine group(41.6umol/l->32.3umol/l) than control group(46.3umol/l->25.2umol/l)(p<0.05). Changes of FC and AC were similar in both groups. Levels of cholesterol and triglyreride were similar in both groups. Days of regaining birth weight were faster in carnitine group than control group(15.3+/-3.4 vs 20. 8+/-11.1 days)(p<0.05). Rate of weight gain for two weeks were significantly faster than carnitine group than control group(p<0.05). No significant differences in clinical outcome were found. CONCLUSIONS: Carnitine supplementation in VLBW infants receiving TPN has an supportive nutritional regimen in that it reduces decrement in carnitine level and facilitate weight gain.
Biomarkers
;
Birth Weight
;
Carnitine*
;
Cholesterol
;
Fatty Acids
;
Humans
;
Incidence
;
Infant*
;
Infant, Very Low Birth Weight*
;
Metabolism
;
Parenteral Nutrition, Total
;
Parturition
;
Plasma
;
Triglycerides
;
Weight Gain
8.Correlation between Expression of Insulin-like Growth Factor-I Receptor and Clinicopathologic Prognostic Factors in Invasive Ductal Carcinoma of the Breast.
So Yeong OH ; Myoung Jae KANG ; Woo Sung MOON ; Ho Yeul CHOI
Journal of Korean Breast Cancer Society 2002;5(2):118-124
PURPOSE: The insulin-like growth factor-I receptor (IGF-IR) is a member of the transmembrane tyrosine kinase family that regulates various biological processes. These processes include maintaining optimal cell growth, establishing and maintaining the transformed phenotype, tumorigenesis for several types of cells, and antiapoptosis. This study investigated the immunohistochemical expression of IGF-IR in relation with the expression of the estrogen receptor (ER), the progesteron receptor (PR), proliferative activity (Ki-67) as well as with the other conventional clinicopathlogical parameters in breast cancer. METHODS: This study was performed on paraffin sections from 64 invasive ductal breast carcinoma specimens by immunohistochemistry using rabbit polyclonal antibodies to the IGF-I receptor. RESULTS: IGF-IR expression was detected in 56 (87.5%) cases. The immunohistochemical stains for the IGF-IR were scored according to a semi quantitative scoring system. IGF-IR staining was positively correlated with the ER status, but not significantly with the PR, lymph node status, tumor size, histological grade, and proliferative activity. The Ki-67 labeling index showed a significant correlation with the tumor grade and ER status. CONCLUSION: The IGF-IR may play a role in estrogen-mediated growth and the pathogenesis of breast cancer.
Antibodies
;
Biological Processes
;
Breast Neoplasms
;
Breast*
;
Carcinogenesis
;
Carcinoma, Ductal*
;
Coloring Agents
;
Estrogens
;
Humans
;
Immunohistochemistry
;
Lymph Nodes
;
Paraffin
;
Phenotype
;
Protein-Tyrosine Kinases
;
Receptor, IGF Type 1
9.Adenoid Basal Cell Tumor of the Prostate: A case report.
Joo Heon KIM ; Woo Sung MOON ; Myoung Jae KANG ; Dong Geun LEE ; Jae Y RO
Korean Journal of Pathology 2000;34(7):534-536
Adenoid basal cell tumor of the prostate is a rare tumorous lesion that can be misdiagnosed as adenocarcinoma of the prostate. The malignant potential of adenoid basal cell tumor remains uncertain due to small number of reported cases. This 66-year-old man presented with symptoms of urinary tract obstruction. Under the impression of benign prostatic hyperplasia, a transurethral resection of the prostate (TURP) was performed. The patient was alive with no evidence of recurrence or metastasis 15 months after TURP. Microscopically, most of the lesions were composed of nodular collections of small nests of basaloid cells with peripheral palisading, and clusters of tumor cells forming cribriform pattern. Multiple areas of basal cell hyperplasia and atypical basal cell hyperpalsia were also observed. The coexistence of basal cell hyperplasia, atypical basal cell hyperpalsia, and adenoid basal cell tumor with cribriform pattern in this case supports a morphologic continuum from the benign hyperplastic lesion to malignant neoplasia.
Adenocarcinoma
;
Adenoids*
;
Aged
;
Humans
;
Hyperplasia
;
Neoplasm Metastasis
;
Prostate*
;
Prostatic Hyperplasia
;
Recurrence
;
Transurethral Resection of Prostate
;
Urinary Tract
10.A Case of Partial DiGeorge Syndrome.
Myoung Hee HAN ; Sung Su MOON ; Soo Chul CHO ; Dae Yeol LEE
Journal of Korean Society of Pediatric Endocrinology 1997;2(1):139-144
DiGeorge syndrome, a developmental defect of the third and fourth pharyngeal pouches, is characterized by aplasia or hypoplasia of the thymus and parathyroid glands and by conotruncal cardiac malformation. This syndrome is usually associated with deletion of long arm in chromosome 22 (22q11-). We experienced a case of partial DiGeorge syndrome in a 2-month-old male who had hospitalized because of recurrent hypocalcemic tetany and tetralogy of Fallot. Immunologic studies revealed the decreased percentage of T lymphocyte and increased percentage of B lymphocyte. Chromosomal study with high resolution banding, showed 46, XY, 22q13 deletion. We report a case of partial Digeorge syndrome with a brief review of literatures.
Arm
;
Chromosomes, Human, Pair 22
;
DiGeorge Syndrome*
;
Humans
;
Infant
;
Lymphocytes
;
Male
;
Parathyroid Glands
;
Tetany
;
Tetralogy of Fallot
;
Thymus Gland